West-Ward Amoxicillin Suspension: Label Error May Cause Incorrect Dosage
West-Ward Pharmaceuticals recalls Amoxicillin oral suspension due to potential label errors affecting dosage accuracy. This recall applies to specific lot numbers and requires verification of the color-coded strength panel.
Lower-risk recall
Labeling: Label Error on Declared Strength: Some bottles miss a color coded panel where the strength of the product is typically displayed.
Contact the company
What happened, in plain English
West-Ward Pharmaceuticals is recalling Amoxicillin oral suspension because some bottles lack a color-coded panel that shows the product's strength. This error could lead to incorrect dosing, especially for prescription use. Read more at govinfonow.com/recall/42260-west-ward-amoxicillin-suspension-label-error-may-cause-incorrect-dosage.
Source Summary by GovInfoNow · govinfonow.com/recall/42260-west-ward-amoxicillin-suspension-label-error-may-cause-incorrect-dosage · Updated October 9, 2026 · FDA enforcement record: FDA #D-0147-2017
Cite this page
“West-Ward Amoxicillin Suspension: Label Error May Cause Incorrect Dosage.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/42260-west-ward-amoxicillin-suspension-label-error-may-cause-incorrect-dosage. Based on FDA recall #D-0147-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0147-2017%22&limit=1).
Why it’s dangerous
The label error means some bottles do not have the color-coded panel that indicates the product's strength. This could result in incorrect dosing if the user relies on the label to determine the correct amount of medication.
Who’s affected
Prescription holders of Amoxicillin oral suspension (400 mg/5 mL, 100 mL) manufactured by Hikma Pharmaceuticals. Patients using the product without verifying the color-coded strength panel are at risk of incorrect dosing.
How to tell if you have this one
Check for the color-coded panel that displays the product strength on the bottle. The product is labeled as Amoxicillin for Oral suspension, USP 400 mg/5 mL, 100 mL (when reconstituted), Rx only, manufactured by Hikma Pharmaceuticals, with NDC 0143-9887-01 and lot number AS1466A.
- Brand
West-Ward- Category
Drug
What to do — step by step
Verify Label Panel
Check if the bottle has the color-coded panel that shows the product strength. If missing, stop using the product.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 7 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0147-2017 (November 4, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0147-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.